Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

Drs Kathryn J. Ruddy and Narjust Florez discuss fertility, pregnancy, sexual health, delays in diagnosis, and the financial burden of young-onset cancer survivorship.

Data published for the first time ever by the NHS show patients in the poorest communities and those from an Asian or Asian British background are more likely to be waiting longer than 18 weeks than ...

Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red ...

Researchers explore glioblastoma's genetic complexity using innovative spatial profiling, aiming to enhance treatment ...

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...

An item in Republicans’ sweeping policy and tax bill intended to block Medicaid dollars from flowing to Planned Parenthood, the nation’s biggest abortion provider, is also hitting a major medical ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

During a live event, Andrew H. Lipsky, MD, and participants discussed balancing efficacy, safety, and patient preferences ...

Understanding actionable mutations and educating patients on the safety profiles of targeted therapies are essential for the ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...